Market Research

Clinical Microbiology Market By Product (Laboratory Instruments, Automated Culture System, Reagents) , By Disease (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodonta

Best Price Guarantee Length Publisher Published Date SKU
from $4,425 300 Pages Allied Market Research August, 2024 ALMR19510216
Best Price Guarantee
Price from $4,425
Length 300 Pages
Publisher Allied Market Research
Published Date August, 2024
SKU ALMR19510216

Clinical Microbiology Market By Product (Laboratory Instruments, Automated Culture System, Reagents) , By Disease (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033


Clinical Microbiology Market Expected to Garner $9.7 Billion by 2033, Growing at a CAGR of 7.5%

The global clinical microbiology market is expected to grow primarily due to the growing healthcare-associated infections (HAIs) and rising demand for accurate testing solutions. The North America region is predicted to witness profitable growth by 2033.

As per the report published by Research Dive, the global clinical microbiology market was valued at $4.8 billion in 2023 and is expected to register a revenue of $9.7 billion by 2033 at a CAGR of 7.5% during the forecast period 2024-2033.

Dynamics of the Market

The increasing healthcare-associated infections (HAIs), rising adoption of molecular diagnostic techniques, and the growing demand for rapid & accurate testing solutions are expected to make the clinical microbiology market a highly profitable one in the forecast period. Besides, the growing emphasis on personalized medicine is predicted to drive the market growth.

However, according to market analysts, stringent regulatory requirements for product approval and limited access to testing facilities might restrain the growth of the market.

Advances in clinical microbiology technologies and innovations in automated microbial identification & susceptibility testing systems present significant opportunities for clinical microbiology market growth. Moreover, expansion of healthcare facilities in developing regions is expected to further boost the market growth in the coming years.

Key Players of the Market

The major players of the clinical microbiology market include Becton, Dickinson and Company, Thermo Fisher Scientific, bioMérieux SA, Bio-Rad Laboratories, Bruker Corporation, Hoffmann-La Roche AG, Danaher Corporation, Hologic, and Abbott Laboratories.

What the Report Covers

In addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter’s five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).

Key Market Segments

By Product

Laboratory Instruments
Automated Culture System
Reagents

By Disease

Respiratory Diseases
Bloodstream Infections
Gastrointestinal Diseases
Sexually Transmitted Diseases
Urinary Tract Infections
Periodontal Diseases
Others

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Russia
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Thailand
Malaysia
Indonesia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
UAE
Argentina
Rest of LAMEA

Key Market Players

BD
Hardy Diagnostics, Inc.
BioMerieux SA
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories
F. HOFFMANN-LA ROCHE AG
Bruker Corporation
Danaher Corporation
Abbott Laboratories
Hologic


CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Laboratory Instruments
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Automated Culture System
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Reagents
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: CLINICAL MICROBIOLOGY MARKET, BY DISEASE
5.1. Market Overview
5.1.1 Market Size and Forecast, By Disease
5.2. Respiratory Diseases
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Bloodstream Infections
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Gastrointestinal Diseases
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Sexually Transmitted Diseases
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Urinary Tract Infections
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
5.7. Periodontal Diseases
5.7.1. Key Market Trends, Growth Factors and Opportunities
5.7.2. Market Size and Forecast, By Region
5.7.3. Market Share Analysis, By Country
5.8. Others
5.8.1. Key Market Trends, Growth Factors and Opportunities
5.8.2. Market Size and Forecast, By Region
5.8.3. Market Share Analysis, By Country
CHAPTER 6: CLINICAL MICROBIOLOGY MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Product
6.2.3. Market Size and Forecast, By Disease
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Clinical Microbiology Market
6.2.5.1. Market Size and Forecast, By Product
6.2.5.2. Market Size and Forecast, By Disease
6.2.6. Canada Clinical Microbiology Market
6.2.6.1. Market Size and Forecast, By Product
6.2.6.2. Market Size and Forecast, By Disease
6.2.7. Mexico Clinical Microbiology Market
6.2.7.1. Market Size and Forecast, By Product
6.2.7.2. Market Size and Forecast, By Disease
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Product
6.3.3. Market Size and Forecast, By Disease
6.3.4. Market Size and Forecast, By Country
6.3.5. France Clinical Microbiology Market
6.3.5.1. Market Size and Forecast, By Product
6.3.5.2. Market Size and Forecast, By Disease
6.3.6. Germany Clinical Microbiology Market
6.3.6.1. Market Size and Forecast, By Product
6.3.6.2. Market Size and Forecast, By Disease
6.3.7. Italy Clinical Microbiology Market
6.3.7.1. Market Size and Forecast, By Product
6.3.7.2. Market Size and Forecast, By Disease
6.3.8. Spain Clinical Microbiology Market
6.3.8.1. Market Size and Forecast, By Product
6.3.8.2. Market Size and Forecast, By Disease
6.3.9. UK Clinical Microbiology Market
6.3.9.1. Market Size and Forecast, By Product
6.3.9.2. Market Size and Forecast, By Disease
6.3.10. Russia Clinical Microbiology Market
6.3.10.1. Market Size and Forecast, By Product
6.3.10.2. Market Size and Forecast, By Disease
6.3.11. Rest Of Europe Clinical Microbiology Market
6.3.11.1. Market Size and Forecast, By Product
6.3.11.2. Market Size and Forecast, By Disease
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Product
6.4.3. Market Size and Forecast, By Disease
6.4.4. Market Size and Forecast, By Country
6.4.5. China Clinical Microbiology Market
6.4.5.1. Market Size and Forecast, By Product
6.4.5.2. Market Size and Forecast, By Disease
6.4.6. Japan Clinical Microbiology Market
6.4.6.1. Market Size and Forecast, By Product
6.4.6.2. Market Size and Forecast, By Disease
6.4.7. India Clinical Microbiology Market
6.4.7.1. Market Size and Forecast, By Product
6.4.7.2. Market Size and Forecast, By Disease
6.4.8. South Korea Clinical Microbiology Market
6.4.8.1. Market Size and Forecast, By Product
6.4.8.2. Market Size and Forecast, By Disease
6.4.9. Australia Clinical Microbiology Market
6.4.9.1. Market Size and Forecast, By Product
6.4.9.2. Market Size and Forecast, By Disease
6.4.10. Thailand Clinical Microbiology Market
6.4.10.1. Market Size and Forecast, By Product
6.4.10.2. Market Size and Forecast, By Disease
6.4.11. Malaysia Clinical Microbiology Market
6.4.11.1. Market Size and Forecast, By Product
6.4.11.2. Market Size and Forecast, By Disease
6.4.12. Indonesia Clinical Microbiology Market
6.4.12.1. Market Size and Forecast, By Product
6.4.12.2. Market Size and Forecast, By Disease
6.4.13. Rest of Asia-Pacific Clinical Microbiology Market
6.4.13.1. Market Size and Forecast, By Product
6.4.13.2. Market Size and Forecast, By Disease
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Product
6.5.3. Market Size and Forecast, By Disease
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Clinical Microbiology Market
6.5.5.1. Market Size and Forecast, By Product
6.5.5.2. Market Size and Forecast, By Disease
6.5.6. South Africa Clinical Microbiology Market
6.5.6.1. Market Size and Forecast, By Product
6.5.6.2. Market Size and Forecast, By Disease
6.5.7. Saudi Arabia Clinical Microbiology Market
6.5.7.1. Market Size and Forecast, By Product
6.5.7.2. Market Size and Forecast, By Disease
6.5.8. UAE Clinical Microbiology Market
6.5.8.1. Market Size and Forecast, By Product
6.5.8.2. Market Size and Forecast, By Disease
6.5.9. Argentina Clinical Microbiology Market
6.5.9.1. Market Size and Forecast, By Product
6.5.9.2. Market Size and Forecast, By Disease
6.5.10. Rest of LAMEA Clinical Microbiology Market
6.5.10.1. Market Size and Forecast, By Product
6.5.10.2. Market Size and Forecast, By Disease
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. BD
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Hardy Diagnostics, Inc.
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. BioMerieux SA
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Thermo Fisher Scientific Inc.
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Bio-Rad Laboratories
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. F. HOFFMANN-LA ROCHE AG
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Bruker Corporation
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Danaher Corporation
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Abbott Laboratories
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Hologic
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. CLINICAL MICROBIOLOGY MARKET FOR AUTOMATED CULTURE SYSTEM, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 6. CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. CLINICAL MICROBIOLOGY MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. CLINICAL MICROBIOLOGY MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 16. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 17. U.S. CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 18. U.S. CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 19. CANADA CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 20. CANADA CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 21. MEXICO CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 22. MEXICO CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 23. EUROPE CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 24. EUROPE CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 25. EUROPE CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 26. FRANCE CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 27. FRANCE CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 28. GERMANY CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 29. GERMANY CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 30. ITALY CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 31. ITALY CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 32. SPAIN CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 33. SPAIN CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 34. UK CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 35. UK CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 36. RUSSIA CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 37. RUSSIA CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 38. REST OF EUROPE CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 39. REST OF EUROPE CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 40. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 41. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 42. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 43. CHINA CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 44. CHINA CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 45. JAPAN CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 46. JAPAN CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 47. INDIA CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 48. INDIA CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 49. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 50. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 51. AUSTRALIA CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 52. AUSTRALIA CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 53. THAILAND CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 54. THAILAND CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 55. MALAYSIA CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 56. MALAYSIA CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 57. INDONESIA CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 58. INDONESIA CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 59. REST OF ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 60. REST OF ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 61. LAMEA CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 62. LAMEA CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 63. LAMEA CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 64. BRAZIL CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 65. BRAZIL CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 66. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 67. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 68. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 69. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 70. UAE CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 71. UAE CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 72. ARGENTINA CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 73. ARGENTINA CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 74. REST OF LAMEA CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 75. REST OF LAMEA CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2024 - 2033 ($BILLION)
TABLE 76. BD: KEY EXECUTIVES
TABLE 77. BD: COMPANY SNAPSHOT
TABLE 78. BD: OPERATING SEGMENTS
TABLE 79. BD: PRODUCT PORTFOLIO
TABLE 80. BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 81. HARDY DIAGNOSTICS, INC.: KEY EXECUTIVES
TABLE 82. HARDY DIAGNOSTICS, INC.: COMPANY SNAPSHOT
TABLE 83. HARDY DIAGNOSTICS, INC.: OPERATING SEGMENTS
TABLE 84. HARDY DIAGNOSTICS, INC.: PRODUCT PORTFOLIO
TABLE 85. HARDY DIAGNOSTICS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 86. BIOMERIEUX SA: KEY EXECUTIVES
TABLE 87. BIOMERIEUX SA: COMPANY SNAPSHOT
TABLE 88. BIOMERIEUX SA: OPERATING SEGMENTS
TABLE 89. BIOMERIEUX SA: PRODUCT PORTFOLIO
TABLE 90. BIOMERIEUX SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 91. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
TABLE 92. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 93. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
TABLE 94. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 95. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96. BIO-RAD LABORATORIES: KEY EXECUTIVES
TABLE 97. BIO-RAD LABORATORIES: COMPANY SNAPSHOT
TABLE 98. BIO-RAD LABORATORIES: OPERATING SEGMENTS
TABLE 99. BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
TABLE 100. BIO-RAD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 101. F. HOFFMANN-LA ROCHE AG: KEY EXECUTIVES
TABLE 102. F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT
TABLE 103. F. HOFFMANN-LA ROCHE AG: OPERATING SEGMENTS
TABLE 104. F. HOFFMANN-LA ROCHE AG: PRODUCT PORTFOLIO
TABLE 105. F. HOFFMANN-LA ROCHE AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106. BRUKER CORPORATION: KEY EXECUTIVES
TABLE 107. BRUKER CORPORATION: COMPANY SNAPSHOT
TABLE 108. BRUKER CORPORATION: OPERATING SEGMENTS
TABLE 109. BRUKER CORPORATION: PRODUCT PORTFOLIO
TABLE 110. BRUKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 111. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 112. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 113. DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 114. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 115. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 116. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 117. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 118. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 119. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 120. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 121. HOLOGIC: KEY EXECUTIVES
TABLE 122. HOLOGIC: COMPANY SNAPSHOT
TABLE 123. HOLOGIC: OPERATING SEGMENTS
TABLE 124. HOLOGIC: PRODUCT PORTFOLIO
TABLE 125. HOLOGIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL CLINICAL MICROBIOLOGY MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF CLINICAL MICROBIOLOGY MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN CLINICAL MICROBIOLOGY MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCLINICAL MICROBIOLOGY MARKET
FIGURE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SEGMENTATION, BY PRODUCT
FIGURE 11. CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. CLINICAL MICROBIOLOGY MARKET FOR AUTOMATED CULTURE SYSTEM, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. GLOBAL CLINICAL MICROBIOLOGY MARKET SEGMENTATION, BY DISEASE
FIGURE 15. CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. CLINICAL MICROBIOLOGY MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 26. COMPETITIVE DASHBOARD
FIGURE 27. COMPETITIVE HEATMAP: CLINICAL MICROBIOLOGY MARKET
FIGURE 28. TOP PLAYER POSITIONING, 2023
FIGURE 29. BD: NET SALES, 2021-2023 ($BILLION)
FIGURE 30. BD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 31. BD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 32. HARDY DIAGNOSTICS, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 33. HARDY DIAGNOSTICS, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 34. HARDY DIAGNOSTICS, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 35. BIOMERIEUX SA: NET SALES, 2021-2023 ($BILLION)
FIGURE 36. BIOMERIEUX SA: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 37. BIOMERIEUX SA: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 38. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 39. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 40. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 41. BIO-RAD LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 42. BIO-RAD LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 43. BIO-RAD LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 44. F. HOFFMANN-LA ROCHE AG: NET SALES, 2021-2023 ($BILLION)
FIGURE 45. F. HOFFMANN-LA ROCHE AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 46. F. HOFFMANN-LA ROCHE AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 47. BRUKER CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 48. BRUKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 49. BRUKER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 50. DANAHER CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 51. DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 52. DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 53. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 54. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 55. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 56. HOLOGIC: NET SALES, 2021-2023 ($BILLION)
FIGURE 57. HOLOGIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 58. HOLOGIC: REVENUE SHARE, BY REGION, 2023 (%)

$4,425
$7,412

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings